- Home
- SLNH vs NRXS Comparison
SLNH vs NRXS Comparison
Compare SLNH & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNH
- NRXS
- Stock Information
- Founded
- SLNH 1961
- NRXS 2011
- Country
- SLNH United States
- NRXS United States
- Employees
- SLNH N/A
- NRXS N/A
- Industry
- SLNH EDP Services
- NRXS
- Sector
- SLNH Technology
- NRXS
- Exchange
- SLNH Nasdaq
- NRXS Nasdaq
- Market Cap
- SLNH 15.5M
- NRXS 13.0M
- IPO Year
- SLNH N/A
- NRXS 2023
- Fundamental
- Price
- SLNH $0.52
- NRXS $2.41
- Analyst Decision
- SLNH Hold
- NRXS Strong Buy
- Analyst Count
- SLNH 1
- NRXS 1
- Target Price
- SLNH N/A
- NRXS $7.00
- AVG Volume (30 Days)
- SLNH 1.5M
- NRXS 55.7K
- Earning Date
- SLNH 08-14-2025
- NRXS 08-12-2025
- Dividend Yield
- SLNH N/A
- NRXS N/A
- EPS Growth
- SLNH N/A
- NRXS N/A
- EPS
- SLNH N/A
- NRXS N/A
- Revenue
- SLNH $27,891,000.00
- NRXS $3,217,531.00
- Revenue This Year
- SLNH N/A
- NRXS $73.05
- Revenue Next Year
- SLNH N/A
- NRXS $130.42
- P/E Ratio
- SLNH N/A
- NRXS N/A
- Revenue Growth
- SLNH N/A
- NRXS 41.93
- 52 Week Low
- SLNH $0.36
- NRXS $1.33
- 52 Week High
- SLNH $5.31
- NRXS $6.20
- Technical
- Relative Strength Index (RSI)
- SLNH 46.68
- NRXS 42.66
- Support Level
- SLNH $0.43
- NRXS $2.26
- Resistance Level
- SLNH $0.52
- NRXS $2.57
- Average True Range (ATR)
- SLNH 0.06
- NRXS 0.14
- MACD
- SLNH 0.01
- NRXS -0.02
- Stochastic Oscillator
- SLNH 66.67
- NRXS 37.94
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).